ALEXION PHARMACEUTICALS, INC. for ALEXION PHARMACEUTICALS, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R. 5376, Build Back Better Act Issues related to the Orphan Drug Tax Credit
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATIE JONES | — |
Copyright/Patent/Trademark CPT
Issues related to intellectual property, data exclusivity, patent eligibility & patent law reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATIE JONES | — |
Health Issues HCR
H.R. 482/S. 350, Newborn Screening Saves Lives Reauthorization Act of 2021 H.R. 1730/S. 670, Speeding Therapy Access Today Act of 2021 Cures 2.0 Discussion Draft; Diverse and Equitable Participation in Clinical Trials Act Discussion Draft General issues related to orphan disease drugs; FDA modernization policy issues; Reauthorization of newborn screening programs; Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients; general issues related to health equity in rare disease; general issues related to health equity in rare disease and clinical trials; general issues related to diagnostics for patients with rare diseases
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATIE JONES | — |
Medicare/Medicaid MMM
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act H.R. 19, Lower Costs, More Cures Act of 2021 H.R. 5260, Reduced Costs and Continued Cures Act H.R. 5376, Build Back Better Act General issues related to patient access to rare disease therapies, Part B and Part D drugs; issues related to home infusion for Part B patients; Center for Medicare and Medicaid Innovation (CMMI) policy issues; value-based payment arrangements; efforts to improve coding and coverage for rare disease therapies; issues related to low volume Diagnosis Related Groups (DRGs) and rare therapies; general issues related to telemedicine
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATIE JONES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.